Shire PLC (NASDAQ:SHPG) announced a semiannual dividend on Friday, August 11th, Wall Street Journal reports. Stockholders of record on Friday, September 8th will be given a dividend of 0.1527 per share by the biopharmaceutical company on Friday, October 20th. This represents a dividend yield of 0.21%. The ex-dividend date is Thursday, September 7th.

Shire PLC (NASDAQ SHPG) traded down 0.91% on Friday, reaching $148.61. 958,068 shares of the company were exchanged. The stock has a market capitalization of $44.26 billion, a price-to-earnings ratio of 66.49 and a beta of 1.60. Shire PLC has a 52 week low of $147.79 and a 52 week high of $209.22. The stock has a 50-day moving average price of $164.82 and a 200 day moving average price of $172.65.

Shire PLC (NASDAQ:SHPG) last issued its quarterly earnings results on Thursday, August 3rd. The biopharmaceutical company reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.53 by $0.20. The firm had revenue of $3.75 billion during the quarter. Shire PLC had a net margin of 4.70% and a return on equity of 14.10%. The firm’s revenue for the quarter was up 54.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.38 EPS. Analysts forecast that Shire PLC will post $14.93 earnings per share for the current year.

A number of analysts recently weighed in on SHPG shares. Royal Bank Of Canada set a $221.00 price target on shares of Shire PLC and gave the stock a “buy” rating in a research note on Thursday, May 18th. Sanford C. Bernstein reiterated a “market perform” rating and set a $210.00 price target on shares of Shire PLC in a research note on Thursday, July 13th. HSBC Holdings plc upgraded shares of Shire PLC from a “reduce” rating to a “hold” rating in a research note on Thursday, July 6th. Jefferies Group LLC restated a “buy” rating and issued a $216.00 target price (down previously from $239.00) on shares of Shire PLC in a research note on Friday, June 9th. Finally, Stifel Nicolaus reduced their target price on shares of Shire PLC from $250.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, June 9th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $222.27.

TRADEMARK VIOLATION WARNING: This report was reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Dividend History for Shire PLC (NASDAQ:SHPG)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.